Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection
- PMID: 15024179
- DOI: 10.1023/B:JOCI.0000019777.75784.6f
Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection
Abstract
Immunodeficiency related to HIV may increase the incidence of EBV-associated lymphomas, by altering EBV-specific immune control and consequently favoring EBV reactivation. The aim of the present study was to assess the relationship between the decrease of EBV-specific cellular immunity and the increase of EBV reactivation in a prospective cohort of 72 unselected HIV-infected individuals. EBV-specific immunity was evaluated by a highly sensitive IFN-gamma ELISPOT assay using 22 peptides mimicking latent and lytic antigens, and circulating mononuclear (PBMC) EBV DNA load was quantified by real-time quantitative PCR. The mean circulating cell-associated EBV DNA load was higher in HIV-infected patients (639 copies/10(6) PBMC) than in healthy controls (21, n = 14) ( P = 0.005) and was higher in patients with CD4(+) T-cell count below 350/microL than that in patients harboring higher CD4(+) T-cell count (1112 vs. 389, P = 0.003). The mean intensity of EBV-specific cellular responses was lower in HIV-infected patients than in controls ( P = 0.001), even in patients with CD4(+) T-cell count above 350/-microL ( P = 0.007). The number of EBV peptides recognized was lower in HIV-infected patients than in controls (frequency: 0.44 vs. 0.67; P = 0.02), indicating reduced polyclonality in HIV-infected patients. The polyclonality was 1.5-fold lower in HIV-infected patients with CD4(+) T-cell count below 350/-microL ( P =0.007). For EBV load >1000 copies/10(6) PBMC, the levels of cell-associated EBV DNA and those of EBV-specific cellular immunity, either in intensity or in polyclonality, or both, were inversely correlated. These findings demonstrate early impairment of the EBV-specific cellular immune control with progressive increase of EBV reactivation in the course of HIV infection. These observations likely provide a basis for appreciating the risk to develop non-Hodgkin's lymphomas in HIV-infected individuals.
Similar articles
-
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.Blood. 2001 Jul 1;98(1):146-55. doi: 10.1182/blood.v98.1.146. Blood. 2001. PMID: 11418474
-
Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.J Clin Virol. 2012 Mar;53(3):195-200. doi: 10.1016/j.jcv.2011.12.013. Epub 2011 Dec 30. J Clin Virol. 2012. PMID: 22209290
-
Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.Eur J Immunol. 2005 Mar;35(3):796-805. doi: 10.1002/eji.200425792. Eur J Immunol. 2005. PMID: 15724243
-
Immune escape by Epstein-Barr virus associated malignancies.Semin Cancer Biol. 2008 Dec;18(6):381-7. doi: 10.1016/j.semcancer.2008.10.002. Epub 2008 Oct 19. Semin Cancer Biol. 2008. PMID: 18996483 Free PMC article. Review.
-
CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.Curr Mol Med. 2003 Jun;3(4):341-7. doi: 10.2174/1566524033479771. Curr Mol Med. 2003. PMID: 12776989 Review.
Cited by
-
Epstein-Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection.Viruses. 2022 Jan 18;14(2):168. doi: 10.3390/v14020168. Viruses. 2022. PMID: 35215762 Free PMC article.
-
Human T cell aging and the impact of persistent viral infections.Front Immunol. 2013 Sep 13;4:271. doi: 10.3389/fimmu.2013.00271. Front Immunol. 2013. PMID: 24062739 Free PMC article. Review.
-
Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.PLoS One. 2012;7(3):e31753. doi: 10.1371/journal.pone.0031753. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427806 Free PMC article.
-
Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium.J Virol. 2007 Jun;81(11):5484-96. doi: 10.1128/JVI.00171-07. Epub 2007 Mar 21. J Virol. 2007. PMID: 17376918 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials